ANNX
NASDAQ · Biotechnology
Annexon Inc
$4.33
+0.14 (+3.34%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+842.5% upside
Low Target
$23.52
Average Target
$40.81
High Target
$51.70
Current Price
$4.33
Current
$4.33
$4.33
Target
$40.81
$40.81
$23.52
$40.81 avg
$51.70
Scenario Analysis
Bear Case
$23.52
443.2%
Low target
Base Case
$40.81
+842.5%
Avg target
Bull Case
$51.70
+1,094.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$7.18
-39.7% from high
52-Week Low
$2.54
+70.5% from low
Target vs 52W High
$40.81
+468.4% vs high
Next Earnings Report
Nov 16, 2026
8d
until earnings
EPS Est: $-0.29
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |